Regulations.gov document
Attachment 3 - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), GHB and…
Supporting & Related Material · FDA-2008-N-0448 · posted Apr 3, 2012
Key facts
| Document ID | FDA-2008-N-0448-0019 |
|---|---|
| Title | Attachment 3 - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), GHB and Its Precursors GBL: An Emerging Trend Case Study Jazz Pharmaceuticals - Supplement Comment re FDA-2008-N-0448-0008 |
| Document type | Supporting & Related Material |
| Subtype | Reference (external attachments) |
| Agency | FDA |
| Docket | FDA-2008-N-0448 |
| Posted | Apr 3, 2012 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: